Exosomes deliver
Codiak unveils its preclin data on exosomes for PDAC
Codiak BioSciences Inc. founder Raghu Kalluri has published the first animal data demonstrating exosomes can be used as drug delivery vehicles to treat cancer -- not just diagnose it. The findings also mark the unveiling of Codiak’s lead therapeutic program: exosomes that carry an siRNA against mutant KRAS to treat pancreatic cancer.
Exosomes first gained traction as a handle for non-invasive diagnostics because they are shed by cells into the bloodstream, and carry with them nucleic acids and proteins that can provide a window into the biology of the cells that shed them...
BCIQ Company Profiles